The Preuss Foundation, Inc.

THE PREUSS FOUNDATION INTERLEUKIN-2/
LAK CELL TREATMENT OF BRAIN TUMORS
SEMINAR II
September 19, 1988
Dallas, Texas

David Barba, M.D.
NATIONAL INSTITUTES OF HEALTH, NINCDS
Bethesda, Maryland

Robert Dorshe, Ph.D.
DuPont MEDICAL PRODUCTS DEPARTMENT
Wilmington, Delaware

Elizabeth A. Grimm, Ph.D.
UNIVERSITY OF TEXAS SYSTEM CANCER  CENTER
Houston, Texas

Ronald B. Herberman, M.D.
UNIVERSITY OF PITTSBURGH
Pittsburgh, Pennsylvania

Marylou Ingram, M.D.
HUNTINGTON MEDICAL RESEARCH INSTITUTE
Pasadena, California

Paul L. Kornblith, M.D.
ALBERT EINSTEIN COLLEGE OF MEDICINE
Bronx, New York

Carol A. Kruse, Ph.D.
UNIVERSITY OF COLORADO
Denver, Colorado

Maria Kuppner, Ph.D.
UNIVERSITY HOSPITAL, CHUV
Lausanne, Switzerland

Daniel Levitt, M.D., Ph.D.
HOFFMAN La-ROCHE, INCORPORATED
Nutley, New Jersey

Kevin O. Lillehei, M.D.
UNIVERSITY OF COLORADO
Denver, Colorado

P. Juhani Linna, M.D.
E.I. du Pont de NEMOURS & COMPANY
Wilmington, Delaware

M. Stephen Mahaley, Jr., M.D. Ph.D..
UNIVERSITY OF ALABAMA, BIRMINGHAM
Birmingham, Alabama

Randall E. Merchant, Ph.D.
VIRGINIA COMMONWEALTH UNIVERSITY
Richmond, Virginia

Richard P. Moser, M.D.
UNIVERSITY OF TEXAS SYSTEM CANCER CENTER
Houston, Texas

Carolyn Paradise, M.D.
CETUS, INCORPORATED
Emeryville, California

David R. Parkinson, M.D.
UNIVERSITY OF TEXAS SYSTEM CANCER CENTER
Houston, Texas

Stuart Ratner, Ph.D.
MICHIGAN CANCER FOUNDATION
Detroit, Michigan

Mark L. Rosenblum, M.D.
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
San Francisco, California

Stephen Saris, M.D.
NATIONAL INSTITUTES OF HEALTH, NINCDS
Bethesda, Maryland

Robert Selker, M.D.
UNIVERSITY OF PITTSBURGH
Pittsburgh, Pennsylvania

Phillip Streeter, Ph.D.
STANFORD UNIVERSITY
Stanford, California